We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Myriad sues developers of competing breast cancer tests.
- Authors
Scudellari, Megan
- Abstract
The article reports that life science company Myriad Genetics Inc. and its patent-co-owners have filed a patent violation lawsuit to the Utah federal court against Gene by Gene and Ambry Genetics Corp. According to Myriad Genetics spokesperson Ron Rogers, the company is confident that Gene by Gene and Ambry are infringing their patents on complementary DNA (cDNA). It adds that Stanford Law School patent scholar Jacob Sherkow thinks that Myriad may have a big chance to win the case.
- Subjects
MYRIAD Genetics Inc.; PATENT suits; FEDERAL courts; GENE By Gene (Company); AMBRY Genetics Corp.; ROGERS, Ron; ANTISENSE DNA
- Publication
Nature Medicine, 2013, Vol 19, Issue 8, p948
- ISSN
1078-8956
- Publication type
Article
- DOI
10.1038/nm0813-948